TAG / BIG PHARMA

As an FDA executive, Cavazzoni handed Pfizer, her former employer, a record-setting number of approved drugs in one year. And now she’s back. There’s a reason they call it the “revolving door.”

Six percent of Americans have used Ozempic, Wegovy and similar drugs. They’re unwitting experimental subjects.

Psychiatrist Joanna Moncrieff indicts her entire industry for falsely pushing deadly drugs as a “treatment” for depression. Her conclusion: They don’t work. And she’s got the evidence to prove it. 

Shereef Elnahal, Under Secretary for Health at the Department of Veterans Affairs, has a history of financial ties to a pharmaceutical company deeply involved in Ecstasy research. No wonder he keeps pushing for wider acceptance of the deadly drug. 

New FDA rules requiring clear warnings of dangerous side effects in drug ads is setting off alarms at drug companies: How do you legally distract from “Antidepressants may increase suicidal thoughts and actions and worsen depression in children and young adults”?

A review of published psychiatric drug trials shows that successful outcomes are more often published, and unsuccessful outcomes never see the light of day. Is it publication bias?

The FDA has played a substantial role in the crisis which takes some 222 lives each day, recklessly approving dangerous opioid drugs.

As Novo Nordisk CEO Lars Fruergaard Jørgensen prepares to testify before the Senate on the high cost of his designer weight loss drugs, a simple question remains: How can Big Pharma justify raking in billions exploiting the obesity epidemic while harming Americans?